Tagworks Pharmaceuticals is a privately held biotech company
Tagworks Pharmaceuticals has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
Tagworks Pharmaceuticals's investors include New Enterprise Associates, Ysios Capital, Lightstone Ventures, Gilde Healthcare, OostNL.
Tagworks Pharmaceuticals is headquartered in Nijmegen, The Netherlands.
Tagworks Pharmaceuticals is a privately held biotech company
Tagworks Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tagworks Pharmaceuticals — Funding & Investors." VCBacked, June 22, 2023, https://www.vcbacked.co/company/tagworks-pharmaceuticals. Accessed October 23, 2026.
VCBacked. (2023). Tagworks Pharmaceuticals — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/tagworks-pharmaceuticals
{{cite web |title=Tagworks Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/tagworks-pharmaceuticals |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated